This topic contains a solution. Click here to go to the answer

Author Question: A patient wants to enroll in a research study that involves genetic testing but is worried that if ... (Read 126 times)

NguyenJ

  • Hero Member
  • *****
  • Posts: 516
A patient wants to enroll in a research study that involves genetic testing but is worried that if the insurance carrier gets the results, coverage could be denied if the results showed a high risk for developing an expensive health problem.
 
  The nurse should explain that a. insurers cannot use research participants' genetic information against them.
  b. research companies would not sell or otherwise share their participants' results.
  c. this is a valid concern and has been the topic of several recent costly lawsuits.
  d. there is legislation pending on this topic, but no law currently addresses this.

Question 2

A genetics nurse explains to a patient that pharmacogenetics is the study of
 
  a. how individuals respond uniquely to medications.
  b. the effects of drug therapy on developing fetuses.
  c. the way drugs interact with reproductive ability.
  d. using genetic material to create new pharmaceuticals.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Perkypinki

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

A
Under the Genetic Information Nondiscrimination Act (GINA), insurers and employers are prohibited from using research participants' genetic information against them.
Although everyone hopes that research companies would not sell or otherwise share their participants' results, there are enough concerns about the sharing of genetic information that President George W. Bush signed into law GINA in 2008 . Part of GINA addresses the use of research participants' genetic information.
It is true that the patient's concern is valid, but it has been addressed by the creation of GINA, which will hopefully forestall any need for litigation.
Currently, GINA is the law that covers genetic nondiscrimination by insurers and employers.

Answer to Question 2

A
Pharmacogenetics is the field of research that looks at the variability in individuals' responses to medications, including medication transport and metabolism.
Pharmacogenetics is not the study of how drugs affect developing fetuses.
Pharmacogenetics is not the study of how medications interact with reproduction.
Pharmacogenetics is not the field of developing new medications from genetic material.




NguyenJ

  • Member
  • Posts: 516
Reply 2 on: Jul 22, 2018
Wow, this really help


juliaf

  • Member
  • Posts: 344
Reply 3 on: Yesterday
Gracias!

 

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Prostaglandins were first isolated from human semen in Sweden in the 1930s. They were so named because the researcher thought that they came from the prostate gland. In fact, prostaglandins exist and are synthesized in almost every cell of the body.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

For a complete list of videos, visit our video library